Literature DB >> 16511828

A second-site mutation in the initiation codon of WAS (WASP) results in expansion of subsets of lymphocytes in an Wiskott-Aldrich syndrome patient.

Wei Du1, Satoru Kumaki, Toru Uchiyama, Akihiro Yachie, Chung Yeng Looi, Shin Kawai, Masayoshi Minegishi, Narayanaswamy Ramesh, Raif S Geha, Yoji Sasahara, Shigeru Tsuchiya.   

Abstract

Wiskott-Aldrich syndrome (WAS) is caused by mutations in the gene encoding WAS protein (WASP ). Recently, somatic mosaicism caused by reversions or second-site mutations has been reported in some inherited disorders including WAS. In this article, we describe somatic mosaicism in a 15-year-old WAS patient due to a second-hit mutation in the initiation codon. The patient originally had a single-base deletion (c.11delG; p.G4fsX40) in the WAS (WASP) gene, which resulted in a frameshift and abrogated protein expression. Subsequently, a fraction of T and natural killer (NK) cells expressed a smaller WASP, which binds to its cellular partner WASP-interacting protein (WIP). The T and NK cells were found to have an additional mutation in the initiation codon (c.1A>T; p.M1_P5del). The results strongly suggest that the smaller WASP is translated from the second ATG downstream of the original mutation, and not only T cells but also NK cells carrying the second mutation acquired a growth advantage over WASP negative counterparts. To our knowledge, this is the first report describing somatic mosaicism due to a second-site mutation in the initiation codon of any inherited disorders. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16511828     DOI: 10.1002/humu.20308

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  10 in total

Review 1.  Revertant mosaicism in skin: natural gene therapy.

Authors:  Joey E Lai-Cheong; John A McGrath; Jouni Uitto
Journal:  Trends Mol Med       Date:  2010-12-29       Impact factor: 11.951

Review 2.  The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders.

Authors:  Ranran Zhang; Mithun Vinod Shah; Thomas P Loughran
Journal:  Hematol Oncol       Date:  2010-09       Impact factor: 5.271

3.  Revertant somatic mosaicism in the Wiskott-Aldrich syndrome.

Authors:  Brian R Davis; Fabio Candotti
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

4.  The phenomenon of spontaneous genetic reversions in the Wiskott-Aldrich syndrome: a report of the workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4-7, 2006.

Authors:  Donn M Stewart; Fabio Candotti; David L Nelson
Journal:  J Clin Immunol       Date:  2007-08-10       Impact factor: 8.317

Review 5.  Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.

Authors:  Fabio Candotti
Journal:  J Clin Immunol       Date:  2017-10-30       Impact factor: 8.542

6.  A Novel Mutation in a Patient with Wiskott-Aldrich Syndrome

Authors:  Yurday Öncül; Arzu Akyay; İbrahim Tekedereli
Journal:  Turk J Haematol       Date:  2020-01-29       Impact factor: 1.831

7.  Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family.

Authors:  José Navarro-Fernández; María Eugenia de la Morena-Barrio; Emma Martínez-Alonso; Ingunn Dybedal; Mara Toderici; Nataliya Bohdan; Antonia Miñano; Ketil Heimdal; Ulrich Abildgaard; José Ángel Martínez-Menárguez; Javier Corral; Vicente Vicente
Journal:  Oncotarget       Date:  2018-09-04

Review 8.  Reversion Mosaicism in Primary Immunodeficiency Diseases.

Authors:  Hanae Miyazawa; Taizo Wada
Journal:  Front Immunol       Date:  2021-11-16       Impact factor: 7.561

Review 9.  WIP remodeling actin behind the scenes: how WIP reshapes immune and other functions.

Authors:  Elad Noy; Sophia Fried; Omri Matalon; Mira Barda-Saad
Journal:  Int J Mol Sci       Date:  2012-06-21       Impact factor: 6.208

10.  Evolution of highly polymorphic T cell populations in siblings with the Wiskott-Aldrich Syndrome.

Authors:  Maxim I Lutskiy; Jun Y Park; Susanna K Remold; Eileen Remold-O'Donnell
Journal:  PLoS One       Date:  2008-10-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.